Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ursodeoxycholic acid suppresses the malignant progression of colorectal cancer through TGR5-YAP axis
Huan Zhang, Huanji Xu, Chenliang Zhang, et al.
Cell Death Discovery (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

Bile acids and the gut microbiota: metabolic interactions and impacts on disease
Stephanie L. Collins, Jonathan G. Stine, Jordan E. Bisanz, et al.
Nature Reviews Microbiology (2022) Vol. 21, Iss. 4, pp. 236-247
Closed Access | Times Cited: 463
Gut microbiota-derived bile acids in intestinal immunity, inflammation, and tumorigenesis
Jie Cai, Lulu Sun, Frank J. Gonzalez
Cell Host & Microbe (2022) Vol. 30, Iss. 3, pp. 289-300
Open Access | Times Cited: 418
Role of the Gut Microbiota and Its Metabolites in Tumorigenesis or Development of Colorectal Cancer
Ruize Qu, Yi Zhang, Yanpeng Ma, et al.
Advanced Science (2023) Vol. 10, Iss. 23
Open Access | Times Cited: 96
The microbial landscape of colorectal cancer
Maxwell T. White, Cynthia L. Sears
Nature Reviews Microbiology (2023) Vol. 22, Iss. 4, pp. 240-254
Closed Access | Times Cited: 50
Secondary Bile Acids and Tumorigenesis in Colorectal Cancer
Yujing Liu, Shengan Zhang, Wenjun Zhou, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 58
Clinical Practice Guidelines of the Russian Scientific Liver Society, Russian Gastroenterological Association, Russian Association of Endocrinologists, Russian Association of Gerontologists and Geriatricians and National Society for Preventive Cardiology on Diagnosis and Treatment of Non-Alcoholic Liver Disease
В. Т. Ивашкин, M. V. Maevskaya, М. С. Жаркова, et al.
Russian Journal of Gastroenterology Hepatology Coloproctology (2022) Vol. 32, Iss. 4, pp. 104-140
Open Access | Times Cited: 45
The National Consensus statement on the management of adult patients with non-alcoholic fatty liver disease and main comorbidities
M. V. Maevskaya, Yu. V. Kotovskaya, В. Т. Ивашкин, et al.
Terapevticheskii arkhiv (2022) Vol. 94, Iss. 2, pp. 216-253
Open Access | Times Cited: 40
Host-Gut Microbiota Metabolic Interactions and Their Role in Precision Diagnosis and Treatment of Gastrointestinal Cancers
Chunhao Cao, Siran Yue, Aiping Lu, et al.
Pharmacological Research (2024) Vol. 207, pp. 107321-107321
Open Access | Times Cited: 12
Postbiotics in colorectal cancer: intervention mechanisms and perspectives
Wei Xie, Yu-Sen Zhong, Xuejian Li, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 10
Impact of Plant-Based Dietary Fibers on Metabolic Homeostasis in High-Fat Diet Mice via Alterations in the Gut Microbiota and Metabolites
Elizabeth Howard, Rachel Meyer, Savanna N. Weninger, et al.
Journal of Nutrition (2024) Vol. 154, Iss. 7, pp. 2014-2028
Open Access | Times Cited: 8
Ginsenoside Rh4 inhibits colorectal cancer via the modulation of gut microbiota-mediated bile acid metabolism
Xue Bai, Zhiguang Duan, Jianjun Deng, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 8
New Insights into Bile Acids Related Signaling Pathways in the Onset of Colorectal Cancer
Cristiana Caliceti, Angela Punzo, Alessia Silla, et al.
Nutrients (2022) Vol. 14, Iss. 14, pp. 2964-2964
Open Access | Times Cited: 35
Gut Microbial Metabolites on Host Immune Responses in Health and Disease
Jong-Hwi Yoon, Jun-Soo Do, Priyanka Velankanni, et al.
Immune Network (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 17
Beneficial insights into postbiotics against colorectal cancer
Dingka Song, Xiuli Wang, Yongjing Ma, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 17
Bile acid metabolism in health and ageing-related diseases
Xiaojun Li, Chu Fang, Ruihua Zhao, et al.
Biochemical Pharmacology (2024) Vol. 225, pp. 116313-116313
Closed Access | Times Cited: 6
Therapeutic role of ursodeoxycholic acid in colitis-associated cancer via gut microbiota modulation
Qilang He, Jinjie Wu, Jia Ke, et al.
Molecular Therapy (2022) Vol. 31, Iss. 2, pp. 585-598
Open Access | Times Cited: 24
Gut microbiota-mediated ursodeoxycholic acids regulate the inflammation of microglia through TGR5 signaling after MCAO
Feng Zhang, Yiting Deng, Huidi Wang, et al.
Brain Behavior and Immunity (2023) Vol. 115, pp. 667-679
Closed Access | Times Cited: 15
Understanding the role of ursodeoxycholic acid and gut microbiome in non-alcoholic fatty liver disease: current evidence and perspectives
Qingyi Mao, Beibei Lin, Wenluo Zhang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5
Update on the development of TGR5 agonists for human diseases
Wangrui Jin, Mingyue Zheng, Yihua Chen, et al.
European Journal of Medicinal Chemistry (2024) Vol. 271, pp. 116462-116462
Closed Access | Times Cited: 5
Gut microbial metabolites in cancer therapy
Panwei Song, Zhi Peng, Xiaohuan Guo
Trends in Endocrinology and Metabolism (2024)
Closed Access | Times Cited: 5
Hyodeoxycholic acid inhibits colorectal cancer proliferation through the FXR/EREG/EGFR axis
Qiang Pang, Shansong Huang, Xiaodong Li, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 12
Open Access
Exploring Chemoprevention in Colorectal Cancer for Patients with Inflammatory Bowel Disease: Mechanisms of Action and Clinical Aspects
Fotios S. Fousekis, Konstantinos Mpakogiannis, Panagiotis Filis, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 229-229
Open Access
Carcinogenic and anticancer activities of microbiota-derived secondary bile acids
Mobina Kouhzad, Friedrich Götz, Tahereh Navidifar, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
The effects of ursodeoxycholic acid on Parkinson’s disease, a mechanistic review of the recent evidence
Seyed Mehrad Razavi, Niusha Esmaealzadeh, Mahshid Ataei, et al.
Metabolic Brain Disease (2025) Vol. 40, Iss. 2
Closed Access
Salting-out assisted liquid-liquid extraction for UPLC-MS/MS determination of bile acids and kynurenine-, indole- and serotonin-pathway metabolites of tryptophan in human serum of healthy probands
Celine Oanes, Marina Alexeeva, Kjetil Søreide, et al.
Journal of Chromatography B (2025) Vol. 1255, pp. 124519-124519
Closed Access
Page 1 - Next Page

Scroll to top